2018
Glycogenic hepatopathy
Khoury J, Zohar Y, Shehadeh N, Saadi T. Glycogenic hepatopathy. Hepatobiliary & Pancreatic Diseases International 2018, 17: 113-118. PMID: 29709217, DOI: 10.1016/j.hbpd.2018.02.006.Peer-Reviewed Original ResearchConceptsGlycogenic hepatopathyLiver biopsyLiver diseaseRight upper quadrant abdominal painUpper quadrant abdominal painEnd-stage liver diseaseNonalcoholic fatty liver diseaseUncontrolled diabetes mellitusQuadrant abdominal painFatty liver diseaseRoutine blood testsTight glycemic controlLiver glycogen accumulationPubMed database searchAbdominal painClinical responseElevated liverDiabetes mellitusGlycemic controlClinical presentationBlood testsPhysical examinationMedical historyNoninvasive testsLiver enzymes
2016
Severe Elevation of Liver Enzymes Does Not Necessarily Require Treatment Interruption in Patients Treated With a Combination of Paritaprevir/Ritonavir/Ombitasvir Plus Dasabuvir for HCV Infection
Saadi T, Khoury J. Severe Elevation of Liver Enzymes Does Not Necessarily Require Treatment Interruption in Patients Treated With a Combination of Paritaprevir/Ritonavir/Ombitasvir Plus Dasabuvir for HCV Infection. Journal Of Clinical Gastroenterology 2016, 50: 799. PMID: 27380458, DOI: 10.1097/mcg.0000000000000587.Commentaries, Editorials and LettersMeSH Keywords2-NaphthylamineAlanine TransaminaseAnilidesAntiviral AgentsAspartate AminotransferasesCarbamatesCyclopropanesDrug Therapy, CombinationFemaleHepatitis C, ChronicHumansLactams, MacrocyclicMacrocyclic CompoundsMiddle AgedProlineRibavirinRitonavirSulfonamidesUracilValineWithholding Treatment